Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Apollo surpasses target with $5.4bn close for debut secondaries fund as liquidity demand surges
Apollo surpasses target with $5.4bn close for debut secondaries fund as liquidity demand surges Apollo Global Management has raised $5.4bn for its first secondaries fund, S3 Equity and Hybrid Solutions, as institutional demand for liquidity continues to grow amid...
CVC Growth Funds exit Omada in strategic sale to GRO Fund III and Kirk Kapital
CVC Growth Funds exit Omada in strategic sale to GRO Fund III and Kirk Kapital CVC Growth Funds and GRO Fund II have exited their investment in Omada, the Denmark-based identity governance software provider, through a sale to GRO Fund III and Kirk Kapital. Financial...
Brynwood Partners acquires Chef Boyardee from Conagra in $600m carve-out deal
Brynwood Partners acquires Chef Boyardee from Conagra in $600m carve-out deal Brynwood Partners has agreed to acquire the iconic Chef Boyardee brand from Conagra Brands for $600m through its portfolio company Hometown Food. The deal marks the largest acquisition in...